PREETI VEMURI: Open Payments
NPI 1548318488 · BARRINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 40 payments from 12 companies in 2025. Trend: 2023 $982 · 2024 $1,096 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $192 |
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| Optinose US, Inc. | 5 | $113 |
| Genentech USA, Inc. | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| GENZYME CORPORATION | 3 | $74 |
| ALK-Abello, Inc | 3 | $61 |
| Pharming Healthcare, Inc. | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $30 |
| BioCryst US Sales Co., LLC | 1 | $28 |
Products named: Xhance, NUCALA, TEZSPIRE, Xolair, CUVITRU, TRELEGY ELLIPTA, Odactra, AYVAKIT.
Industry payments across IL — which companies pay providers there.
